# Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC

> **NCT04042935** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 5 (actual)

## Conditions studied

- HNSCC

## Interventions

- **DRUG:** Alpha Lipoic Acid

## Key facts

- **NCT ID:** NCT04042935
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-27
- **Primary completion:** 2021-02-19
- **Final completion:** 2021-09-24
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04042935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04042935, "Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04042935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*